Accelerating access to medicines in a changing world.
作者信息
Kettler Hannah, Lehtimaki Susanna, Schwalbe Nina
机构信息
Seattle, United States of America (USA).
Spark Street Advisors, New York, USA.
出版信息
Bull World Health Organ. 2020 Sep 1;98(9):641-643. doi: 10.2471/BLT.19.249664. Epub 2020 Jul 8.
Abstract
摘要
相似文献
1
Accelerating access to medicines in a changing world.在不断变化的世界中加速药品可及性。
Bull World Health Organ. 2020 Sep 1;98(9):641-643. doi: 10.2471/BLT.19.249664. Epub 2020 Jul 8.
2
Ensuring access to essential medicines: some economic considerations.确保基本药物的可及性：一些经济考量
Spec Law Dig Health Care Law. 2003 Jul(291):9-25.
3
Essential medicines out of reach for most people.大多数人无法获得基本药物。
Indian J Med Sci. 2008 Dec;62(12):520-1.
4
A global accountability mechanism for access to essential medicines.一个获取基本药物的全球问责机制。
Lancet. 2018 Dec 8;392(10163):2418-2420. doi: 10.1016/S0140-6736(18)32986-6.
5
Gaps in access to essential medicines and health products for noncommunicable diseases and mental health conditions.在获取用于治疗非传染性疾病和精神健康状况的基本药物和保健产品方面存在的差距。
Bull World Health Organ. 2020 Sep 1;98(9):582-582A. doi: 10.2471/BLT.20.272658.
6
Accelerating access to essential medicines in the WHO South-East Asia Region: opportunities for greater engagement and better evidence.加快在世卫组织东南亚区域获取基本药物：加强参与和获取更好证据的机遇
WHO South East Asia J Public Health. 2018 Sep;7(2):59-61. doi: 10.4103/2224-3151.239414.
7
Introductory note: The access to Essential Medicines Campaign.引言：基本药物获取运动
Trop Med Int Health. 2001 Nov;6(11):955-6. doi: 10.1046/j.1365-3156.2001.00797.x.
8
Improving global access to medicines for non-communicable diseases.改善全球非传染性疾病药品的可及性。
Lancet Glob Health. 2014 Oct;2(10):e561-2. doi: 10.1016/S2214-109X(14)70189-5.
9
World pharmaceutical developments.全球制药业发展动态
World Hosp Health Serv. 2002;38(2):1.
10
The morally uncomfortable global drug gap.道德层面令人不安的全球药物差距。
Clin Pharmacol Ther. 2007 Nov;82(5):610-4. doi: 10.1038/sj.clpt.6100359. Epub 2007 Sep 26.
引用本文的文献
1
Understanding the regulatory-procurement interface for medicines in Africa via publicly available information on standards, implementation, and enforcement in five countries.通过五个国家关于标准、实施和执行的公开信息来了解非洲药品监管与采购之间的关系。
J Pharm Policy Pract. 2025 Jan 9;18(1):2436898. doi: 10.1080/20523211.2024.2436898. eCollection 2025.
2
We Cannot Win the Access to Medicines Struggle Using the Same Thinking That Causes the Chronic Access Crisis.我们不能用导致慢性获取危机的思维方式来赢得药品获取斗争。
Health Hum Rights. 2021 Jun;23(1):119-127.
3
Increasing efficiency in vaccine Production: A primer for change.提高疫苗生产效率：变革入门指南。
Vaccine X. 2021 Aug;8:100104. doi: 10.1016/j.jvacx.2021.100104. Epub 2021 Jun 16.
4
Recommendations for acceleration of vaccine development and emergency use filings for COVID-19 leveraging lessons from the novel oral polio vaccine.利用新型口服脊髓灰质炎疫苗的经验教训，加速COVID-19疫苗研发和紧急使用申请的建议。
NPJ Vaccines. 2021 Apr 22;6(1):63. doi: 10.1038/s41541-021-00325-4.
本文引用的文献
1
Health Technology Assessment: Global Advocacy and Local Realities Comment on "Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness".卫生技术评估：全球倡导与本地现实 评“全民健康覆盖的优先事项制定：我们需要基于证据的审议程序，而不仅仅是更多成本效益证据”。
Int J Health Policy Manag. 2017 Apr 1;6(4):233-236. doi: 10.15171/ijhpm.2016.118.
Zotero 插件